Semaglutides FLOW trial subsequently showed a 24% reduction in kidney-disease progression, prompting payers to waive prior authorizations for diabetic nephropathy cases
It is therefore a precious ally in a strategy to support cellular metabolism and the proper functioning of vital organs
Agnihotri SK, Shen R, Li J, Gao X, Bueler H
GLP-1 for PCOS Fatty liver (MASLD/MASH) What the 2026 evidence actually shows on GLP-1 and liver fat separated from the hype
The principle of Strict Liability applies: athletes are responsible for any prohibited substance in their system, regardless of intent. Vigilance with all substances, including supplements, is crucial
While the research is still very early, a few small human studies hint that BPC157 might help with certain chronic pain conditions